Your browser doesn't support javascript.
loading
Suspected cancer symptoms and blood test results in primary care before a diagnosis of lung cancer: a case-control study.
McDonald, Laura; Carroll, Robert; Harish, Akash; Tanna, Nikhil; Mehmud, Faisal; Alikhan, Raza; Ramagopalan, Sreeram V.
Afiliación
  • McDonald L; Centre for Observational Research & Data Sciences, Bristol-Myers Squibb, Uxbridge, UB8 1DH, United Kingdom.
  • Carroll R; Centre for Observational Research & Data Sciences, Bristol-Myers Squibb, Uxbridge, UB8 1DH, United Kingdom.
  • Harish A; Mu-Sigma, Bengaluru, 560066, India.
  • Tanna N; Bristol-Myers Squibb, Uxbridge, UB8 1DH, United Kingdom.
  • Mehmud F; Bristol-Myers Squibb, Uxbridge, UB8 1DH, United Kingdom.
  • Alikhan R; University Hospital of Wales, Cardiff & Vale University Health Board, CF14 4XW, United Kingdom.
  • Ramagopalan SV; Centre for Observational Research & Data Sciences, Bristol-Myers Squibb, Uxbridge, UB8 1DH, United Kingdom.
Future Oncol ; 15(33): 3755-3762, 2019 Nov.
Article en En | MEDLINE | ID: mdl-31668096
ABSTRACT

Aim:

To compare symptoms and blood test results prior to cancer diagnosis in individuals who developed lung cancer and those who did not. Patients &

methods:

Nested case-control study, lung cancer patients were matched to up four controls with no record of cancer. Differences in symptoms and blood test results were investigated in the 2-year period prior to diagnosis.

Results:

26,379 lung cancer patients were matched to 92,125 controls. Elevated C-reactive protein (CRP) was independently predictive of lung cancer at every 2-month interval 12 months prior to diagnosis. Elevated CRP in conjunction with at least one symptom was associated with greater than fourfold higher odds of lung cancer.

Conclusion:

CRP may be a prediagnostic marker for lung cancer, and when present with other symptoms could facilitate the investigation of high-risk individuals.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Atención Primaria de Salud / Proteína C-Reactiva / Biomarcadores de Tumor / Detección Precoz del Cáncer / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Aspecto: Equity_inequality Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Future Oncol Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Atención Primaria de Salud / Proteína C-Reactiva / Biomarcadores de Tumor / Detección Precoz del Cáncer / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Aspecto: Equity_inequality Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Future Oncol Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
...